Carvana Quietly Became the Most Crowded Tiger Cub Trade of Q2 2026

Most crowded trades announce themselves. Nvidia, Alphabet, the power utilities feeding AI data centers — you can see the pile-up forming in real time because every fund letter mentions it.

Carvana was not that. It showed up in the Q2 2026 13F filings as something closer to a coordinated re-entry, and almost nobody framed it that way because the filings landed the same week everyone was arguing about semiconductor exposure.

The numbers

Across the second quarter, the additions clustered in a way that is hard to write off as coincidence:

• Viking Global (Ole Andreas Halvorsen) raised its stake roughly 343%, to about 12.3 million shares worth around $811 million
• Lone Pine Capital (Stephen Mandel) added roughly 500%
• Durable Capital Partners (Henry Ellenbogen) added roughly 575%
• Coatue Management (Philippe Laffont) added to its position alongside aggressive builds in Micron and Amazon
• CAS Investment Partners (Clifford Sosin) added roughly 397%
• RV Capital (Rob Vinall) added roughly 367%

Zoom out and the picture is messier — 461 institutions added CVNA in the quarter while 509 trimmed. Capital Research Global Investors bought roughly 9.2 million shares; T. Rowe Price sold about 4.2 million. So this was not the whole market moving one way.

What makes it interesting is who moved. Viking, Lone Pine, Coatue and Durable all trace their lineage, directly or philosophically, back to Tiger Management. They screen the same way, hire from the same pool, and — this matters — tend to be early rather than late on high-multiple compounders. When four of them independently arrive at the same mid-cap name in the same 90 days, it's usually because a shared framework flagged something, not because they're copying each other.

You can see the overlap structure for yourself on the InvestorLens overlap tool, which is built precisely for spotting these convergences before the financial press names them.

What they were probably underwriting

The fundamentals gave them a reason. Carvana's Q2 2026 print in late July was a record: 197,000 retail units sold, $513 million in net income, $769 million in adjusted EBITDA. For a company that spent 2022 and 2023 as a leveraged-balance-sheet cautionary tale, posting half a billion in quarterly net income is a different business entirely.

But here's the timing problem, and it's the reason 13F data needs to be read carefully rather than copied. These positions were built during the quarter that ended June 30 — before that earnings report. The funds were buying into the setup, not the confirmation. If you saw the 13F in mid-August and bought, you were buying after the news, at a materially different price.

That's the recurring lesson in 13F filing data: the snapshot tells you what a manager concluded, not when they concluded it, and never what they paid.

The overhang nobody underwrote

There's a second layer, and it's the part that makes the convergence genuinely instructive rather than just a nice signal.

Through the first half of 2026, Carvana carried two non-fundamental risks. The first was Mark Walter's position — 30 million Class A and 30 million Class B shares, roughly $2 billion — and persistent concern that he might be forced to liquidate into the open market to cover outside obligations. The second was a cluster of securities investigations stemming from a short-seller report circulated in January.

Neither shows up anywhere in a 13F. You cannot see a governance overhang in a holdings table. What you can see is that sophisticated managers sized meaningful positions anyway — which implies they'd done the work and concluded the forced-sale risk was overstated. Reports later confirmed Walter's stake is pledged as collateral to Citi, which substantially reduces the odds of an open-market dump. The stock responded.

That's the actual value of reading concentrated positions from disciplined funds: not the ticker, but the implied judgment about risks the filing itself can't show you.

Where it stands

CVNA traded around $70.72 on September 11, with a consensus "Moderate Buy" and a mean analyst target near $85. The Tiger cohort is sitting on positions established at prices we won't know until, well, never — 13Fs don't disclose cost basis.

The more useful question for anyone tracking institutional flow isn't whether to follow them in. It's what happens at the next filing. A crowded position among funds that share a screening framework is also a position that can unwind in a correlated way. If two of these four trim in Q3, the exit is likely to be noisier than the entry was.

The Q3 filings are due in mid-November. That's when we find out whether this was conviction or consensus.

---

Data sourced from public SEC 13F filings. Educational research only — not investment advice.